+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Chronic Idiopathic Constipation Therapeutic Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025

  • ID: 4802097
  • Report
  • May 2019
  • Region: Global
  • 100 pages
  • Infinium Global Research
UP TO OFF
until Jun 30th 2020
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Astellas Pharma, Inc.
  • Bayer AG
  • Boehringer Ingelheim GmbH
  • GlaxoSmithKline Plc.
  • Ironwood Pharmaceuticals
  • Pfizer, Inc.
  • MORE
The report on the global chronic idiopathic constipation therapeutic market provides qualitative and quantitative analysis for the period from 2017 to 2025. The report predicts the global chronic idiopathic constipation therapeutic market to grow with a healthy CAGR over the forecast period from 2019-2025. The study on chronic idiopathic constipation therapeutic market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2017 to 2025.

The report on chronic idiopathic constipation therapeutic market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global chronic idiopathic constipation therapeutic market over the period of 2017 to 2025. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global chronic idiopathic constipation therapeutic market over the period of 2017 to 2025. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings
1) Drivers
  • Rapidly changing lifestyle and modern food habits
  • Raising awareness about the treatment
  • Easy accessibility of over-the-counter drugs for chronic idiopathic constipation
2) Restraints
  • Poor diagnosis rate
  • Availability of alternative treatments
3) Opportunities
  • Extensive research in effective drugs manufacturing for treatment of chronic idiopathic constipation
Research Methodology

A) Primary Research
The primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders associated with the author
2. Internal and External subject matter experts
3. Professionals and participants from the industry
The primary research respondents typically include
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.

B) Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include
1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered
The global chronic idiopathic constipation therapeutic market is segmented on the basis of drug class, route of administration, and distribution channel.

The Global Chronic Idiopathic Constipation Therapeutic Market by Drug Class
  • Emollients
  • Laxatives
  • Bulk-forming Agents
  • Osmotic Agents
  • Other Drug Class
The Global Chronic Idiopathic Constipation Therapeutic Market by Route of Administration
  • Oral
  • Parental
The Global Chronic Idiopathic Constipation Therapeutic Market by Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
Company Profiles

The companies covered in the report include
  • GlaxoSmithKline Plc.
  • Bayer AG
  • Astellas Pharma, Inc.
  • Sanofi S.A.
  • Pfizer, Inc.
  • Ironwood Pharmaceuticals
  • Boehringer Ingelheim GmbH
  • Other Companies
What does this report deliver?
1. Comprehensive analysis of the global as well as regional markets of the chronic idiopathic constipation therapeutic market.
2. Complete coverage of all the segments in the chronic idiopathic constipation therapeutic market to analyze the trends, developments in the global market and forecast of market size up to 2025.
3. Comprehensive analysis of the companies operating in the global chronic idiopathic constipation therapeutic market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Astellas Pharma, Inc.
  • Bayer AG
  • Boehringer Ingelheim GmbH
  • GlaxoSmithKline Plc.
  • Ironwood Pharmaceuticals
  • Pfizer, Inc.
  • MORE
1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches

2. Executive Summary
2.1. Chronic Idiopathic Constipation Therapeutic Market Highlights
2.2. Chronic Idiopathic Constipation Therapeutic Market Projection
2.3. Chronic Idiopathic Constipation Therapeutic Market Regional Highlights

3. Global Chronic Idiopathic Constipation Therapeutic Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. Growth Matrix Analysis
3.4.1. Growth Matrix Analysis by Drug Class
3.4.2. Growth Matrix Analysis by Route Of Administration
3.4.3. Growth Matrix Analysis by Distribution Channel
3.4.4. Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Chronic Idiopathic Constipation Therapeutic Market

4. Chronic Idiopathic Constipation Therapeutic Market Macro Indicator Analysis

5. Global Chronic Idiopathic Constipation Therapeutic Market by Drug Class
5.1. Emollients
5.2. Laxatives
5.3. Bulk-forming Agents
5.4. Osmotic Agents
5.5. Other Drug Class

6. Global Chronic Idiopathic Constipation Therapeutic Market by Route of Administration
6.1. Oral
6.2. Parental

7. Global Chronic Idiopathic Constipation Therapeutic Market by Distribution Channel
7.1. Hospital Pharmacies
7.2. Retail Pharmacies
7.3. Online Pharmacies

8. Global Chronic Idiopathic Constipation Therapeutic Market by Region 2019-2025
8.1. North America
8.1.1. North America Chronic Idiopathic Constipation Therapeutic Market by Drug Class
8.1.2. North America Chronic Idiopathic Constipation Therapeutic Market by Route Of Administration
8.1.3. North America Chronic Idiopathic Constipation Therapeutic Market by Distribution Channel
8.1.4. North America Chronic Idiopathic Constipation Therapeutic Market by Country
8.2. Europe
8.2.1. Europe Chronic Idiopathic Constipation Therapeutic Market by Drug Class
8.2.2. Europe Chronic Idiopathic Constipation Therapeutic Market by Route Of Administration
8.2.3. Europe Chronic Idiopathic Constipation Therapeutic Market by Distribution Channel
8.2.4. Europe Chronic Idiopathic Constipation Therapeutic Market by Country
8.3. Asia-Pacific
8.3.1. Asia-Pacific Chronic Idiopathic Constipation Therapeutic Market by Drug Class
8.3.2. Asia-Pacific Chronic Idiopathic Constipation Therapeutic Market by Route Of Administration
8.3.3. Asia-Pacific Chronic Idiopathic Constipation Therapeutic Market by Distribution Channel
8.3.4. Asia-Pacific Chronic Idiopathic Constipation Therapeutic Market by Country
8.4. RoW
8.4.1. RoW Chronic Idiopathic Constipation Therapeutic Market by Drug Class
8.4.2. RoW Chronic Idiopathic Constipation Therapeutic Market by Route Of Administration
8.4.3. RoW Chronic Idiopathic Constipation Therapeutic Market by Distribution Channel
8.4.4. RoW Chronic Idiopathic Constipation Therapeutic Market by Sub-region

9. Company Profiles and Competitive Landscape
9.1. Competitive Landscape in the Global Chronic Idiopathic Constipation Therapeutic Market
9.2. Companies Profiles
9.2.1. GlaxoSmithKline Plc.
9.2.2. Bayer AG
9.2.3. Astellas Pharma, Inc.
9.2.4. Sanofi S.A.
9.2.5. Pfizer, Inc.
9.2.6. Ironwood Pharmaceuticals
9.2.7. Boehringer Ingelheim GmbH
9.2.8. Other Companies

10. Appendix
10.1. Primary Research Findings and Questionnaire
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • GlaxoSmithKline Plc.
  • Bayer AG
  • Astellas Pharma, Inc.
  • Sanofi S.A.
  • Pfizer, Inc.
  • Ironwood Pharmaceuticals
  • Boehringer Ingelheim GmbH
Note: Product cover images may vary from those shown
Adroll
adroll